Atomi Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,909
Closed -$918K 795
2024
Q1
$918K Sell
31,909
-71
-0.2% -$2.13K 0.08% 196
2023
Q4
$1.05M Buy
31,980
+2,932
+10% +$79.7K 0.15% 128
2023
Q3
$809K Buy
+29,048
New +$950K 0.27% 95

Other funds holding ARKG

Atomi Financial Group's ARKG Position: Q2 2024 in Review

Atomi Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 31,909 shares — an estimated $918K sold.

Atomi Financial Group first reported a position in ARKG in Q3 2023 and held it in 3 quarters. The position peaked at $1.05M in Q4 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Atomi Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Atomi Financial Group sold 31,909 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $918K.
  • Atomi Financial Group first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 3 quarters.
  • Atomi Financial Group's ARK Genomic Revolution ETF position peaked at $1.05M in Q4 2023.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Atomi Financial Group's 13F filing for Q2 2024, filed 26 Jul 2024.